Related references
Note: Only part of the references are listed.Mesenchymal stem cell therapy: Two steps forward, one step back
James Ankrum et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Sleuthing the Source of Regeneration by MSCs
Mark Pittenger
CELL STEM CELL (2009)
C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation
Ingrid U. Schraufstatter et al.
JOURNAL OF IMMUNOLOGY (2009)
Why are MSCs therapeutic? New data: new insight
Al Caplan
JOURNAL OF PATHOLOGY (2009)
Bone marrow stromal cells attenuate sepsis via prostaglandin E-2-dependent reprogramming of host macrophages to increase their interleukin-10 production
Krisztian Nemeth et al.
NATURE MEDICINE (2009)
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
Guangwen Ren et al.
CELL STEM CELL (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Cancer and complement
Suzanne Ostrand-Rosenberg
NATURE BIOTECHNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses
Hirokazu Ohtaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation
Jenny Tjernberg et al.
TRANSPLANTATION (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Complement-targeted therapeutics
Daniel Ricklin et al.
NATURE BIOTECHNOLOGY (2007)
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
O. Ringden et al.
LEUKEMIA (2007)
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
K. Le Blanc et al.
LEUKEMIA (2007)
Recent advances into the understanding of mesenchymal stem cell trafficking
James M. Fox et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions
Darwin J. Prockop et al.
BLOOD (2007)
Complement and coagulation: strangers or partners in crime?
Maciej M. Markiewski et al.
TRENDS IN IMMUNOLOGY (2007)
Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin
Madan Katragadda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structures of complement component C3 provide insights into the function and evolution of immunity
BJC Janssen et al.
NATURE (2005)
Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells
ME Groh et al.
EXPERIMENTAL HEMATOLOGY (2005)
Recognition and clearance of apoptotic cells: a role for complement and pentraxins
AJ Nauta et al.
TRENDS IN IMMUNOLOGY (2003)
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
K Le Blanc et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Share Paper
